Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / By country / Austria

Peptide legality · Austria · updated 2026-09-22

Are peptides legal in Austria?

Restricted

Peptides are legal in Austria only as authorised, prescription-only medicines dispensed by a pharmacy against a doctor's prescription; unapproved research peptides such as BPC-157 and TB-500 have no marketing authorisation and cannot be lawfully sold for human use in Austria.

Legal status overview

Peptides are restricted in Austria: those that are approved medicines are prescription-only, while unapproved 'research' peptides cannot be lawfully sold for human use. The framework is the Austrian Medicines Act (Arzneimittelgesetz, AMG), which transposes EU pharmaceutical law and requires a marketing authorisation before any medicinal product is placed on the market, with prescription status set under the Prescription Requirement Act (Rezeptpflichtgesetz). The regulator is the Federal Office for Safety in Health Care (BASG); any peptide with pharmacological activity can fall under the AMG even if it is not marketed as a medicine.

Key points

  • Peptides intended for human use are governed in Austria by the Austrian Medicines Act (Arzneimittelgesetz, AMG), which transposes EU pharmaceutical legislation and requires a marketing authorisation before a medicinal product may be placed on the market. [1]
  • Under Austria's AMG, any peptide with pharmacological activity can meet the definition of a medicinal product even if it is not marketed as a medicine, so such peptides cannot be lawfully sold for human use in Austria without authorisation. [3]
  • GLP-1 peptides such as semaglutide (and retatrutide) are prescription-only medicines in Austria and are not sold to consumers for personal use outside the pharmacy/prescription channel. [3]
  • The prescription status of medicines in Austria, including peptide drugs, is classified under the Prescription Requirement Act (Rezeptpflichtgesetz) and published by BASG in the Austrian Medicinal Product Index. [4]
  • Austria's national medicines regulator is the Federal Office for Safety in Health Care (BASG), and medicines fall into either non-prescription (OTC) or prescription-only categories requiring a doctor's Rezept before a pharmacist may dispense. [6]
  • No Austria-specific source setting exact personal-import allowances for peptides was located; as prescription-only or unauthorised medicines, research peptides generally cannot be personally imported without a prescription and applicable import authorisation, which reflects general inference from AMG/EU medicines law rather than a peptide-specific rule. (no source found)

Compound-by-compound status

BPC-157BPC-157 is not an authorised medicine in Austria and, as a pharmacologically active peptide falling under the AMG's medicinal-product definition, cannot be lawfully sold for human use there. [3]
Semaglutide / GLP-1 (e.g., Ozempic®, Wegovy®, retatrutide)Semaglutide and other GLP-1 peptides are legal in Austria only as prescription-only medicines and are not sold for personal use outside the prescription channel. [3]
TB-500 (thymosin beta-4)TB-500 is not an authorised medicine in Austria and, as a pharmacologically active peptide covered by the AMG, cannot be lawfully sold for human use there. [3]
HGH / somatropinHuman growth hormone (somatropin) is available in Austria only as a prescription-only medicine; no Austria-specific source distinguishing it further was located, so this reflects the general AMG/prescription framework rather than a somatropin-specific rule. (no source found)

Frequently asked questions

Can I buy peptides in Austria without a prescription?

No. In Austria peptide medicines such as semaglutide are prescription-only, and unapproved research peptides have no marketing authorisation and cannot be lawfully sold for human use. [3]

Is BPC-157 legal in Austria?

BPC-157 is not approved as a medicine in Austria; as a pharmacologically active peptide it falls under the Austrian Medicines Act and cannot be lawfully sold for human use. [3]

Who regulates peptides in Austria?

Peptides in Austria are regulated by the Federal Office for Safety in Health Care (BASG) under the Austrian Medicines Act (AMG), which requires marketing authorisation and sets prescription status. [1]

Can I bring peptides into Austria for personal use?

Likely not for unapproved research peptides: no peptide-specific Austrian import allowance was found, and as prescription-only or unauthorised medicines they generally cannot be personally imported without a prescription and any required import authorisation. This answer is general inference from AMG/EU medicines law, not a peptide-specific source. (no source found)

General information based on the sourced research above, not legal advice. Laws change and enforcement varies; for a specific situation in Austria, consult a licensed attorney or the national regulator.